March 29, 2016
Jeffrey D. Marrazzo is co-founder and CEO of Spark Therapeutics, Inc. (NASDAQ: ONCE), a gene therapy leader developing one-time, life-altering treatments to transform the lives of patients with debilitating diseases. Under Jeff’s leadership, Spark has raised more than $365 million, established a global collaboration with Pfizer in hemophilia B, and advanced its lead program for rare, blinding conditions through a successful Phase 3 clinical trial. Previously, Jeff built and sold the first genetic testing benefit management and pharmacogenomics medicines company to CVS Caremark.
Students must register in advance: entrepreneurship.wharton.upenn.edu/eir/ (Signups open March 15)